Program Description: 

This course will provide an overview of different types of acquired thrombocytopenia.  It will help clinicians gain familiarity with the pathogenesis of acquired thrombocytopenia and be able to establish a differential diagnosis.  Thrombocytopenia is among the most common reason for consultation with a hematologist for both in-patients and out-patients.  There are different disorders which can cause a low platelet count and put a patient at risk for bleeding. The course will help clinicians to understand the differences among the different underlying disorders and how to appropriately manage impacted patients.

This program is sponsored by an unrestricted educational grant by: Dova Pharmaceutical

ACCME Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis (ISTH). The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.

 

AMA Credit Designation Statement:

The Medical College of Wisconsin designates this Live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1 hours of participation for continuing education for allied health professionals.

Target audience: 

This activity is intended for physicians involved in the diagnosis and management of patients who have a low platelet count. 

Learning objectives: 
​- Understand the pathophysiology of heparin-induced thrombocytopenia (HIT)
- Understand the approach to the clinical diagnosis of HIT
- Appreciate the role of clinical assessment and scoring systems in establishing a diagnosis and to make a decision regarding test initiation
- Apply rational laboratory diagnostic strategies based on clinical suspicion
- Appreciate the role of functional tests in avoiding over-diagnosis in HIT
- Provide therapeutic options and strategies for patients with HIT
- Be able discuss management of specific clinical cases like cardiac surgery patients
- Be familiar with anticoagulant regimens that can be used to treat patients with HIT
Faculty & credentials: 

 

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

  • Geoffrey Horlait, MD
  • Isabelle Michaux, MD

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

NameCompanyRole
Yves GruelAspen and LFBSpeaker/Consultant
François Mullier, PharmD, PhD, SpLMStago, Werfen, Nodia, Sysmex, Bayer; Boehringer Ingelheim, Bristol Myers Squibb and PfizerResearch/Speaker
Claire PouplardStagoContractor

 

Contact

Name: 
Lacey Schmeidler
Phone number: 
+1 (919) 929-3807
Email: 
[email protected]
Session date: 
02/25/2019 - 8:00am CST to 02/25/2020 - 12:14pm CST
Location: 
ISTH Webinar Library
Carrboro, NC 27510
United States
See map: Google Maps
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Please login or register to take this course.